Striatal dopaminergic system in dopa-responsive dystonia: A multi-tracer PET study shows increased D2 receptors

Journal of Neural Transmission

Volumn 111, Issue 1, 2004, Pages 59-67

  Rinne, J O ^a   Iivanainen, M ^b   Metsahonkala L ^c   Vainionpaa L ^d   Paakkonen L ^e   Nagren K ^a   Helenius, H ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d OULU UNIVERSITY HOSPITAL   (Finland)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Dopa responsive dystonia; Dopamine; Dopamine receptors; Dopamine transporter; Positron emission tomography; Raclopride

Indexed keywords

8 CHLORO 5 (2,3 DIHYDROBENZOFURAN 7 YL) 2,3,4,5 TETRAHYDRO 3 METHYL 1H 3 BENZAZEPIN 7 OL; CARBON 11; COCAINE DERIVATIVE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; RACLOPRIDE; TRACER;

ADULT; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG UPTAKE; DYSTONIA; FEMALE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PUTAMEN; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CHILD; CORPUS STRIATUM; DOPAMINE; DYSTONIA; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; RECEPTORS, DOPAMINE D2; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0842265664     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-003-0053-3     Document Type: Article

References (48)

1. 11C]raclopride. Mov Disord 12: 33-38
2. Bandmann O, Daniel S, Marsden CD et al. (1996) The GTP-cyclohydrolase I gene in atypical parkinsonian patients: a clinico-genetic study. J Neurol Sci 5: 27-32
3. Berding G, Gratz KF, Kolbe H et al. (1994) [123I]-IBZM SPECT: reconstruction methodology and results in parkinsonism and dystonia. Nuklearmedizin 33: 194-199
4. Boyce S, Rupniak NM, Steventon MJ, Iversen SD (1990) Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson's disease. Neurology 40: 927-933
5. Brooks DJ, Salmon EP, Mathias CJ et al. (1990) The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET. Brain 113: 1539-1552
6. 11C]raclopride and positron emission tomography. Ann Neurol 31: 184-192
7. 11C]raclopride is altered by drugs that modify synaptic dopamine levels. Synapse 13: 350-356
8. Durr A, Tassin J, Vidailhet M et al. (2000) D2 dopamine receptor gene in myoclonic dystonia and essential myoclonus. Ann Neurol 48: 127-128
9. 11C]raclopride binding to D2-dopamine receptors studied by PET - a comparison to the equilibrium analysis. J Cereb Blood Flow Metab 9: 696-708
10. Flaherty AW, Graybiel AM (1994) Anatomy of the basal ganglia. In: Marsden CD, Fahn S (eds) Movement disorders 3. Butterworth-Heinemann, Cambridge, pp 3-27
11. 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann Neurol 34: 423-431
12. Furukawa Y, Shimadzu M, Rajput A et al. (1996) GTP-cyclohydrolase I gene mutation in hereditary progressive and dopa-responsive dystonia. Ann Neurol 39: 609-617
13. Halldin C, Farde L, Högberg T et al. (1991) A comparative PET-study of five carbon-11 or fluorine-18 labelled salicylamides. Preparation and in vitro dopamine D-2 receptor binding. Nucl Med Biol 18: 871-881
14. Ichinose H, Ohye T, Takahashi E et al. (1994) Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nature Genet 8: 236-242
15. Ito Y, Fujita M, Shimada S et al. (1999) Comparison between the decrease of dopamine transporter and that of L-DOPA uptake for detection of early to advanced stage of Parkinson's disease in animal models. Synapse 31: 178-185
16. Jeon BS, Jeong J-M, Park S-S et al. (1998) Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia. Ann Neurol 43: 792-800
17. 11C]N- methylspiperone. J Nucl Med 41: 65-70
18. Kemppainen N, Ruottinen H, Någen K, Rinne JO (2000) PET shows that dopamine D1 and D2 receptors are differentially affected in AD. Neurology 55: 205-209
19. 11C]raclopride and positron emission tomography. Neurology 50: 1028-1032
20. Künig G, Leenders KL, Antonini A et al. (1998) D2 receptor binding in dopa-responsive dystonia. Ann Neurol 44: 758-762
21. Lachowicz J, Sibley D (1997) Molecular characteristics of mammalian dopamine receptors. Pharmacol Toxicol 81: 105-113
22. Laihinen AO, Rinne JO, Ruottinen HM et al. (1994) PET studies on dopamine D1 receptors in the human brain with carbon-11-SCH 39166 and carbon-11-NNC 756. J Nucl Med 35: 1916-1920
23. 11C]-N-methyl-spiperone binding in patients with focal dystonia (torticollis) using positron emission tomography. J Neural Transm [PD Sect] 5: 79-87
24. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16: 834-840
25. Ludecke B, Dworniczak B, Bartholome K (1995) A point mutation in the tyrosine hydroxylase gene associated with Segawa's syndrome. Hum Genet 95: 123-125
26. Meng SZ, Obonai T, Takashima S (1998) A developmental study of the dopamine D2R receptors in the human basal ganglia and thalamus. Early Hum Dev 51: 23-30
27. Meng SZ, Ozawa Y, Itoh M, Takashima S (1999) Developmental and age-related changes of dopamine transporter and dopamine D1 and D2 receptors in human basal ganglia. Brain Res 843: 136-144
28. Montague DM, Lawler CP, Mailman RB, Gilmore JH (1999) Developmental regulation of the dopamine D1 receptor in human caudate and putamen. Neuropsychopharmacology 21: 641-649
29. Naumann M, Pirker W, Reiners K et al. (1997) [123I]beta-CIT single-photon emission computed tomography in dopa-responsive dystonia. Mov Disord 12: 448-451
30. Nygaard TG, Takahashi H, Heiman GA et al. (1992) Long-term treatment response and fluorodopa positron emission tomography scanning of parkinsonism in a family with dopa-responsive dystonia. Ann Neurol 32: 603-608
31. 11C]methyl Inflate. Nucl Med Biol 22: 235-239
32. Peacock L, Jensen G, Nicholson K, Gerlach J (1999) Extrapyramidal side effects during combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys. Eur Arch Psychiatry Clin Neurosci 249: 221-226
33. Pearce RK, Jackson M, Britton DR et al. (1999) Actions of the D1 agonist A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated 1-dopa-primed common marmorsets. Psychopharmacology 142: 51-60
34. Rajput AH, Gibb WRG, Zhong XH et al. (1994) Dopa-responsive dystonia: pathological and biochemical observations in a case. Ann Neurol 35: 396-402
35. 11C]raclopride. J Cereb Blood Flow Metab 13: 310-314
36. 11C]β-CFT in early Parkinson's disease. Synapse 21: 97-103
37. 11C]raclopride. J Neurol Sci 132: 156-161
38. 11C]β-CFT is reduced in Alzheimer's disease assessed by positron emission tomography. Neurology 50: 152-156
39. 18F]dopa positron emission tomography. Ann Neurol 30: 24-30
40. Seeman P, Bzowej N, Guan H-G et al. (1987) Human brain dopamine receptors in children and aging adults. Synapse 1: 399-404
41. 3H]raclopride: implications for positron emission tomography of the human brain. Synapse 3: 96-97
42. Segawa M, Hosaka A, Miyagawa F et al. (1976) Hereditary progressive dystonia with marked diurnal fluctuations. Adv Neurol 24: 667-672
43. Snow BJ, Nygaard TG, Takahashi H, Calne DB (1993) Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism. Ann Neurol 34: 733-738
44. Suhara T, Fukuda H, Inoue O et al. (1991) Age-related changes in human D1 dopamine receptors measured by positron emission tomography. Psychopharmacology 103: 41-45
45. Turjanski N, Bhatia K, Burn DJ et al. (1993) Comparison of striatal [18F]dopa uptake in adult-onset dystonia-parkinsonism, Parkinson's disease, and dopa-responsive dystonia. Neurology 43: 1563-1568
46. Wilson JM, Levey AI, Rajput A et al. (1996) Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease. Neurology 47: 718-726
47. 3H]raclopride binding in the rat brain. Synapse 9: 188-194
48. Zar JH (1984) Biostatistical analysis, 2nd ed. Prentice Hall New Jersey